Latest Production News

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

EQ Resources Ltd updates investors on its proposed acquisition of Tungsten Metals Group, highlighting completed due diligence but pending definitive agreements as discussions continue beyond the exclusivity period.

Mirvac's 1H25 results reveal a modest decline in EBIT and operating profit, yet the company signals strong growth prospects fueled by residential sales momentum, sustainable development, and strategic capital partnering.

Charter Hall Retail REIT reported a 3.0% same property net property income growth and a stable 98.7% occupancy rate in its 2025 half-year results, while integrating the Hotel Property Investments acquisition to enhance future income growth.

Charter Hall Retail REIT reports solid 1H FY25 results with $73.1 million operating earnings and strategic moves to enhance income growth, including a major stake in Hotel Property Investments Ltd.

Infomedia Ltd has agreed to acquire a 50% stake in European AI startup Intellegam GmbH for €6.1 million, marking a strategic leap to integrate cutting-edge generative AI into its automotive data solutions. The deal sets a clear path to full ownership within five years, underpinning Infomedia’s innovation-driven growth agenda.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.

AMP reported a robust FY24 with underlying NPAT rising 15.1% to $236 million, driven by disciplined cost management and strong cash flows. The company declared a final dividend of 1.0 cents per share and is set to launch a new digital bank in February 2025, signaling strategic growth in wealth and banking sectors.

GQG Partners delivered robust full-year 2024 results, marked by a 26.9% increase in funds under management and nearly 47% growth in net revenue, underpinned by strong investment performance and strategic initiatives including Private Capital Solutions and a new Abu Dhabi office.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.